1. UBS Lux Equity Fund Biotech USD
UBS Lux Equity Fund Biotech USD P-acc
Fee
2.25%
ISIN
LU0069152568
Holdings
5
Fondsfinans Norge B
Fee
0.99%
ISIN
NO0013168708
Holdings
25
We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with Fondsfinans Norge, we have 26 holdings where Schibsted is the largest holding (7.34), followed by Aker BP (6.69) and Orkla (6.44).
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Fondsfinans Norge.
| UBS Lux Equity Fund Biotech USD | Fondsfinans Norge |
|---|---|
|
10.04 % |
 7.34 % |
|
9.21 % |
6.69 % |
 4.66 % |
6.44 % |
|
4.13 % |
6.12 % |
|
3.75 % |
5.46 % |
| - |
4.57 % |
| - |
4.08 % |
| - |
3.64 % |
| - |
3.36 % |
| - |
3.04 % |
| - |
3.03 % |
| - |
2.72 % |
| - |
2.68 % |
| - |
 2.67 % |
| - |
 2.66 % |
| - |
2.64 % |
| - |
2.49 % |
| - |
2.4 % |
| - |
2.4 % |
| - |
2.4 % |
| - |
2.36 % |
| - |
2.27 % |
| - |
2.11 % |
| - |
2.05 % |
| - |
2.05 % |
The list of fund holdings was last updated on September 10, 2025.
